Skip to main content
Log in

Blastocystis hominis: neutral red supravital staining and its application to in vitro drug sensitivity testing

  • ORIGINAL PAPER
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

A simple in vitro drug sensitivity testing system for Blastocystis hominis clinical isolates was developed. Application of supravital staining by neutral red allowed quantitative viability assessment. Four xenic cultures, isolated from human sources, were grown in modified monophasic Robinson's medium and tested for sensitivities to nine available drugs. Assessment was done using the cell-count method from air-dried preparations after supravital staining with neutral red. Also, the light absorbence method was evaluated. Trimethoprim, metronidazole, quinacrine, tetracycline, paromomycin, and two new antiprotozoal drugs, nitazoxanide and deacetyl-nitazoxanide, showed cytostatic or cytocidal effects on all or some Blastocystis isolates. Chloroquine and sulphamethoxazole did not demonstrate any effect at the concentrations studied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 20 November 1998 / Received last revision: 27 December 1999 / Accepted: 29 December 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vdovenko, A., Williams, J. Blastocystis hominis: neutral red supravital staining and its application to in vitro drug sensitivity testing. Parasitol Res 86, 573–581 (2000). https://doi.org/10.1007/PL00008533

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00008533

Keywords

Navigation